Raymond James Financial
ALT icon

Raymond James Financial’s Altimmune ALT Stock Holding History

Raymond James Financial’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65K Sell
21,384
-32,412
-60% -$96.8K ﹤0.01% 5228
2026
Q1 		$166K Sell
53,796
-2,063
-4% -$8.76K ﹤0.01% 4926
2025
Q4 		$202K Buy
55,859
+28,187
+102% +$123K ﹤0.01% 4789
2025
Q3 		$104K Buy
27,672
+1,703
+7% +$6.58K ﹤0.01% 4743
2025
Q2 		$101K Buy
25,969
+11,309
+77% +$61.2K ﹤0.01% 4871
2025
Q1 		$73.3K Buy
14,660
+2,420
+20% +$15.3K ﹤0.01% 4598
2024
Q4 		$88.3K Buy
+12,240
New +$93.5K ﹤0.01% 4543

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's ALT Position: Q2 2026 in Review

Raymond James Financial reduced its Altimmune (ALT) stake by 60% in Q2 2026, selling an estimated $96.8K and leaving 21,384 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #5228.

Raymond James Financial first reported a position in ALT in Q4 2024 and has held it in 7 quarters since. The position peaked at $202K in Q4 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Raymond James Financial held 21,384 shares of Altimmune worth $65K as of Q2 2026.
  • Raymond James Financial sold 32,412 Altimmune shares in Q2 2026, an estimated $96.8K.
  • Altimmune made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5228 holding.
  • Raymond James Financial first reported a position in Altimmune in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Altimmune position peaked at $202K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.